- World rank, all time
- #38,100 of 42,892
- Rank in Germany
- #1,827 of 2,077
- Research works
- 128 ▲ 705% vs 2013–17
- Citations
- 724 5.7 per fractional work
- Top-10% rate
- 3.8% record average 16.5%
- Open access
- 36% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 11.4×. Every wedge is a field page.
- Immunology and Microbiology 11.4×
- Biochemistry, Genetics and Molecular Biology 5.2×
- Veterinary 5.2×
- Pharmacology, Toxicology and Pharmaceutics 4.0×
- Medicine 2.2×
- Engineering 0.6×
- Chemistry 0.5×
- Nursing 0.5×
- Economics, Econometrics and Finance 0.4×
- Computer Science 0.4×
- Social Sciences 0.1×
- Neuroscience 0.1×
- Materials Science 0.1×
- Environmental Science 0.0×
- Decision Sciences 0.0×
Who are the top researchers at Charles River Laboratories (Germany)?
Ranked on the composite score, Julia Schüler and Eva Oswald lead among researchers whose main affiliation is Charles River Laboratories (Germany).
- 1 Julia Schüler Germany · #1,151,568 worldwide 49 citations · 49 works
- 2 Eva Oswald Germany · #1,268,300 worldwide 11 citations · 15 works
Which keywords describe research at Charles River Laboratories (Germany)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Tumor Microenvironment, Tumor Regression, Cancer Immunotherapy, Gene Therapy, Immunity, Tumor Targeting and Immune Checkpoint Blockade.
- Mutational Signatures
- Cancer Genomics
- Polarization
- Activation
- Angiogenesis
- Warburg Effect
- HIF-1
- Therapeutic Antibodies
- Monoclonal Antibodies
- Chimeric Antigen Receptor
- Lymphoma
- Antigen Presentation
- Bacterial Therapy
- Tumor Metastasis
- Cancer Stem Cells
- Immune Checkpoint Blockade
- Tumor Targeting
- Immunity
- Cancer Immunotherapy
- Tumor Microenvironment
- Immunotherapy
- Tumor Regression
- Gene Therapy
- Inflammation
- Cancer
- PD-1 and PD-L1
- Epithelial-Mesenchymal Transition
- Arginine Deprivation
- Innate Immunity
- Dendritic Cells
- CAR T Cells
- Glycosylation
- Fc Receptors
- Gene Expression
- Targeted Therapy
- Regenerative Medicine
- Cell Culture
- Macrophage
- Biomedical Engineering
- Hackathons
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Immunotherapy8▲ 22×10 topics
- Tumor Microenvironment6▲ 28×5 topics
- Tumor Regression6▲ 110×2 topics
- Cancer Immunotherapy5▲ 73×2 topics
- Gene Therapy4▲ 48×4 topics
- Immunity4▲ 22×4 topics
- Inflammation4▲ 4.1×11 topics
- Tumor Targeting4▲ 45×2 topics
- Cancer4▲ 5.6×13 topics
- Immune Checkpoint Blockade4▲ 66×1 topic
- PD-1 and PD-L14▲ 66×1 topic
- Cancer Stem Cells3▲ 160×1 topic
- Epithelial-Mesenchymal Transition3▲ 76×2 topics
- Tumor Metastasis3▲ 125×1 topic
- Arginine Deprivation3▲ 183×1 topic
- Bacterial Therapy3▲ 183×1 topic
- Innate Immunity3▲ 19×3 topics
- Antigen Presentation3▲ 65×1 topic
- Dendritic Cells3▲ 64×1 topic
- Lymphoma3▲ 35×2 topics
- CAR T Cells3▲ 74×1 topic
- Chimeric Antigen Receptor3▲ 74×1 topic
- Glycosylation2▲ 46×2 topics
- Monoclonal Antibodies2▲ 50×2 topics
- Fc Receptors2▲ 80×1 topic
- Therapeutic Antibodies2▲ 63×1 topic
- Gene Expression2▲ 6.8×6 topics
- HIF-12▲ 62×1 topic
- Targeted Therapy2▲ 17×4 topics
- Warburg Effect2▲ 62×1 topic
- Regenerative Medicine2▲ 13×2 topics
- Angiogenesis2▲ 9.6×2 topics
- Cell Culture2▲ 27×2 topics
- Activation1▲ 47×1 topic
- Macrophage1▲ 39×1 topic
- Polarization1▲ 19×2 topics
- Biomedical Engineering1▲ 18×1 topic
- Cancer Genomics1▲ 38×1 topic
- Hackathons1▲ 74×1 topic
- Mutational Signatures1▲ 38×1 topic
Which research topics does Charles River Laboratories (Germany) publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Cancer Cells and Metastasis, Cancer Research and Treatments and Immunotherapy and Immune Responses.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 4 works
- 2 Cancer Cells and Metastasis Oncology 3 works
- 3 Cancer Research and Treatments Biotechnology 3 works
- 4 Immunotherapy and Immune Responses Immunology 3 works
- 5 CAR-T cell therapy research Oncology 3 works
- 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
- 7 Cancer, Hypoxia, and Metabolism Cancer Research 2 works
- 8 Immune cells in cancer Immunology 1 works
- 9 Cancer Genomics and Diagnostics Cancer Research 1 works
- 10 Biomedical and Engineering Education Biomedical Engineering 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Charles River Laboratories (Germany)'s research output changed?
Output in 2018–2022 was 705% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.